132 Annual Meeting Logo - Go to APHA Meeting Page  
APHA Logo - Go to APHA Home Page
Session: Advances in Contraceptive Method Choice and Programmatic Guidelines for Effective Use
3291.0: Monday, November 8, 2004: 2:30 PM-4:00 PM
Advances in Contraceptive Method Choice and Programmatic Guidelines for Effective Use
Expanded contraceptive method choice is vital to attracting more women and men to adopt family planning, and to better meeting needs of current and potential users. Clear guidelines on effective method use (mechanisms of use, who should use, contraindications, standard practice recommendations for effective use, etc.), are essential in order to ensure that clients receive effective methods best suited to their needs. It is imperative that family planning practitioners and anyone involved in managing family planning programs keep up to date on both new contraceptive methods and revised guidelines on existing methods. This panel presents new guidelines from the WHO’s Medical Eligibility Criteria for Contraceptive Use, including guidelines for three new hormonal methods (the combined hormonal ring, combined hormonal patch, and etonogestrel-releasing implant), and three conditions that affect contraceptive effectiveness and use (depression, antiretroviral therapy, and known thrombogenic mutations). Practical research findings on the introduction of a new method in field settings (two-day method), and on use of emergency contraception in the US will help participants better manage introduction and provision of those methods. Finally, college students views on acceptability of new contraceptive and STI prevention methods are presented, demonstrating considerations that product developers need to consider in order to improve effectiveness of products introduced in the future.
Learning Objectives: At the end of this session, participants will be able to: 1) describe new guidelines for use of three new hormonal contraceptive methods 2) name three conditions that have new WHO guidelines for contraceptive use 3) articulate guidelines for contracptive use by women with HIV/AIDS 4) describe results of practical field experience with relatively new methods such as the two day method and emergency contraception 5) Discuss the importance of acceptability research in the development of biomedical prevention methods
Moderator(s):S. Marie Harvey, DrPH
2:30 PMBreaking News: Updates on WHO’s Guidance for Contraceptive Use  [ Recorded presentation ]
Anshu P. Mohllajee, MPH, Kathryn M Curtis, PhD, Mary Lyn Gaffield, PhD, Herbert Peterson, MD
2:43 PMBreaking News: Updates on WHO's Guidelines for Contraceptive Use, Part 2
Anshu P Mohllajee, MPH, Mary Lyn Gaffield, PhD, Kathryn M Curtis, PhD, Herbert Peterson, MD
2:56 PMBreaking News: WHO's Guidance on Contraceptive Use for Women with HIV/AIDS  [ Recorded presentation ]
Anshu P. Mohllajee, MPH, Kathryn M Curtis, PhD, Kavita Nanda, MD, MHS, Herbert Peterson, MD
3:09 PMTwoDay Method: A new, effective family planning option  [ Recorded presentation ]
Marcos Arevalo, MD, MPH
3:21 PMEmergency Contraception (EC): Is it being misused?  [ Recorded presentation ]
Toni L. Felice, PhD, Kay A. Armstrong, MS, Janet Adams, PhD, Paul G. Whittaker, DPhil
3:33 PMCharacteristics of Biomedical HIV/STD/Pregnancy Prevention Methods Preferred by University Women Students
Tina G. Vazin, PhD, Crystal Spivey, MPH, M. Kim Oh, MD, Tina Simpson, MD, Karyn Scissum-Gunn, PhD
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:Population, Family Planning, and Reproductive Health
Endorsed by:APHA-Committee on Women's Rights; International Health; Socialist Caucus; Women's Caucus
CE Credits:CME, Health Education (CHES), Nursing

The 132nd Annual Meeting (November 6-10, 2004) of APHA